These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32017943)

  • 1. Fibulin-7 C-terminal fragment and its active synthetic peptide suppress choroidal and retinal neovascularization.
    Ikeuchi T; Kanan Y; Long D; de Vega S; Hozumi K; Nomizu M; Campochiaro PA; Yamada Y
    Microvasc Res; 2020 May; 129():103986. PubMed ID: 32017943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
    Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of ocular angiogenesis by Notch signaling: implications in neovascular age-related macular degeneration.
    Ahmad I; Balasubramanian S; Del Debbio CB; Parameswaran S; Katz AR; Toris C; Fariss RN
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):2868-78. PubMed ID: 21228388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agents that bind annexin A2 suppress ocular neovascularization.
    Lima e Silva R; Shen J; Gong YY; Seidel CP; Hackett SF; Kesavan K; Jacoby DB; Campochiaro PA
    J Cell Physiol; 2010 Nov; 225(3):855-64. PubMed ID: 20607799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ilimaquinone inhibits neovascular age-related macular degeneration through modulation of Wnt/β-catenin and p53 pathways.
    Son Y; Lim D; Park S; Song IS; Kim JH; Shin S; Jang H; Liu KH; O Y; Song GY; Kang W; Cho YS; Na M; Chung H; Oh S
    Pharmacol Res; 2020 Nov; 161():105146. PubMed ID: 32814173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases.
    Oliner JD; Bready J; Nguyen L; Estrada J; Hurh E; Ma H; Pretorius J; Fanslow W; Nork TM; Leedle RA; Kaufman S; Coxon A
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2170-80. PubMed ID: 22410553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model.
    Kim SY; Kambhampati SP; Bhutto IA; McLeod DS; Lutty GA; Kannan RM
    Exp Eye Res; 2021 Feb; 203():108391. PubMed ID: 33307075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical application of a G-Quartet aptamer targeting nucleolin attenuates choroidal neovascularization in a model of age-related macular degeneration.
    Leaderer D; Cashman SM; Kumar-Singh R
    Exp Eye Res; 2015 Nov; 140():171-178. PubMed ID: 26368850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 Oxidase 2C Inhibition Adds to ω-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization.
    Gong Y; Fu Z; Edin ML; Liu CH; Wang Z; Shao Z; Fredrick TW; Saba NJ; Morss PC; Burnim SB; Meng SS; Lih FB; Lee KS; Moran EP; SanGiovanni JP; Hellström A; Hammock BD; Zeldin DC; Smith LE
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1919-27. PubMed ID: 27417579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
    Gong Y; Shao Z; Fu Z; Edin ML; Sun Y; Liegl RG; Wang Z; Liu CH; Burnim SB; Meng SS; Lih FB; SanGiovanni JP; Zeldin DC; Hellström A; Smith LEH
    EBioMedicine; 2016 Nov; 13():201-211. PubMed ID: 27720395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Role of Adiponectin/AdipoRs Signaling in Choroidal Neovascularization, Age-Related Macular Degeneration, and Diabetic Retinopathy.
    Choubey M; Bora P
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat treatment of retinal pigment epithelium induces production of elastic lamina components and antiangiogenic activity.
    Sekiyama E; Saint-Geniez M; Yoneda K; Hisatomi T; Nakao S; Walshe TE; Maruyama K; Hafezi-Moghadam A; Miller JW; Kinoshita S; D'Amore PA
    FASEB J; 2012 Feb; 26(2):567-75. PubMed ID: 22067481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonist of nucleolin, N6L, inhibits neovascularization in mouse models of retinopathies.
    Darche M; Cossutta M; Caruana L; Houppe C; Gilles ME; Habert D; Guilloneau X; Vignaud L; Paques M; Courty J; Cascone I
    FASEB J; 2020 Apr; 34(4):5851-5862. PubMed ID: 32141122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological Angiogenesis Requires Syndecan-4 for Efficient VEGFA-Induced VE-Cadherin Internalization.
    De Rossi G; Vähätupa M; Cristante E; Arokiasamy S; Liyanage SE; May U; Pellinen L; Uusitalo-Järvinen H; Bainbridge JW; Järvinen TAH; Whiteford JR
    Arterioscler Thromb Vasc Biol; 2021 Apr; 41(4):1374-1389. PubMed ID: 33596666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ocular neovascularization by novel anti-angiogenic compound.
    Gau D; Vignaud L; Francoeur P; Koes D; Guillonneau X; Roy P
    Exp Eye Res; 2021 Dec; 213():108861. PubMed ID: 34822853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid-Derived Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor Are Dispensable for Ocular Neovascularization--Brief Report.
    Liyanage SE; Fantin A; Villacampa P; Lange CA; Denti L; Cristante E; Smith AJ; Ali RR; Luhmann UF; Bainbridge JW; Ruhrberg C
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):19-24. PubMed ID: 26603154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
    Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
    PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF-binding aptides and the inhibition of choroidal and retinal neovascularization.
    Jo DH; Kim S; Kim D; Kim JH; Jon S; Kim JH
    Biomaterials; 2014 Mar; 35(9):3052-9. PubMed ID: 24388818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metrnl inhibits choroidal neovascularization by attenuating the choroidal inflammation via inactivating the UCHL-1/NF-κB signaling pathway.
    Zhang L; Li Y; Wu Z; Shen Q; Zeng C; Liu H; Zhang X; Yang J; Liu Q; Tang D; Ou K; Fang Y
    Front Immunol; 2024; 15():1379586. PubMed ID: 38745648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.